Delivery Order SPE2DB25D2203-SPE2DB25FPSJV
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,032.11 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on August 8, 2025, with a completion date of August 29, 2025, is structured as a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of October 14, 2025. This competitive award, issued on September 22, 2025, utilizes firm fixed price terms and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $157,951.50 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, executed on August 27, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price contract, awarded on September 8, 2025, represents a non-competitive delivery order under an existing contract vehicle and is scheduled for completion by September 29, 2025. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,052.96 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 11, 2025, with an ultimate completion date of September 2, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and...
- The Defense Logistics Agency awarded a delivery order valued at $10,321.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 12, 2025, carries a firm fixed price structure with an ultimate completion date of September 3, 2025. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $5,212.80 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price, competitively awarded contract was issued on September 12, 2025, with an ultimate completion date of October 3, 2025. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents totaling $6,192.66 under a firm fixed price contract type. This award, issued on September 5, 2025, with an ultimate completion date of September 26, 2025, represents a non-competitive delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,052.96 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on August 7, 2025, with an ultimate completion date of August 28, 2025, operates under firm fixed-price terms with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a competitive award to...
- SPE2DB25D2203Indefinite Delivery Contract
- SPE2DB25D2203-SPE2DB25FPSJVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on September 25, 2025, with an ultimate completion date of October 17, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The Varivax vaccine with diluents delivery falls within the company's extensive portfolio of vaccine and pharmaceutical products delivered through the DLA's Medical Supply Chain. The underlying SPE2DX IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/25/25 |